ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 71 filers reported holding ATHIRA PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $51,377 | -84.1% | 17,416 | -86.6% | 0.00% | – |
| Q1 2023 | $323,973 | -39.9% | 129,589 | -23.8% | 0.00% | – |
| Q4 2022 | $538,912 | +13.7% | 170,004 | +6.5% | 0.00% | – |
| Q3 2022 | $474,000 | -77.7% | 159,700 | -77.1% | 0.00% | – |
| Q2 2022 | $2,127,000 | +96.2% | 697,203 | +767.8% | 0.00% | – |
| Q1 2022 | $1,084,000 | -15.6% | 80,341 | -18.6% | 0.00% | – |
| Q4 2021 | $1,285,000 | +59.2% | 98,646 | +14.7% | 0.00% | – |
| Q3 2021 | $807,000 | +34.5% | 86,033 | +46.9% | 0.00% | – |
| Q2 2021 | $600,000 | -45.8% | 58,574 | -2.5% | 0.00% | – |
| Q1 2021 | $1,106,000 | -66.7% | 60,088 | -66.6% | 0.00% | -100.0% |
| Q3 2020 | $3,322,000 | – | 179,933 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 1,630,744 | $21,249,000 | 2.19% |
| VR Adviser, LLC | 1,000,000 | $13,030,000 | 1.78% |
| ACUTA CAPITAL PARTNERS, LLC | 310,030 | $4,040,000 | 1.70% |
| Ikarian Capital, LLC | 860,000 | $11,207,000 | 1.67% |
| Bristlecone Advisors, LLC | 761,563 | $9,923,000 | 1.19% |
| Perceptive Advisors | 6,851,832 | $89,280,000 | 0.69% |
| DAFNA Capital Management LLC | 160,983 | $2,098,000 | 0.53% |
| PATHSTONE FAMILY OFFICE, LLC | 1,442,247 | $18,792,000 | 0.47% |
| Potomac Capital Management, Inc. | 40,000 | $521,000 | 0.46% |
| RTW INVESTMENTS, LP | 1,906,557 | $24,842,000 | 0.36% |